Synthesis of pyrrolo[3,2-d]pyrimidineone derivatives as novel FXa inhibitors.

ID: ALA5236667

Journal: Bioorg Med Chem Lett

Title: Synthesis of pyrrolo[3,2-d]pyrimidineone derivatives as novel FXa inhibitors.

Authors: Yang J, Su B, Liao R, Wang J, Bo S.

Abstract: A series of pyrrolo[3,2-d]pyrimidineone compounds have been designed and synthesized as novel FXa inhibitors. Bioassay of the tested compounds showed moderate to excellent anticoagulant potency in vitro. Further FXa inhibitory and bioactivity evaluation in rats, the FeCl₃-induced venous thrombosis model, showed that the compound 17a has good FXa inhibitory activity (IC₅₀ = 1.57 nM) and in vivo antithrombotic potency. The anticoagulant effects of compound 17a were dose dependent whether in vitro or in vivo. The results further confirmed our hypothesis that the large conjugated structure is an ideal skeleton binding FXa.

CiteXplore: 36634753

DOI: 10.1016/j.bmcl.2023.129127

Patent ID: ┄